135062-02-1
135062-02-1
Chemical Structure
Repaglinide
Synonym(s): AG-EE 623ZW
- CAS No.: 135062-02-1
- Formula:C27H36N2O4
- Molecular Weight:452.59
IUPAC Name: (S)-2-ethoxy-4-(2-((3-methyl-1-(2-(piperidin-1-yl)phenyl)butyl)amino)-2-oxoethyl)benzoic acid
InChIKey: FAEKWTJYAYMJKF-QHCPKHFHSA-N
SMILES: CC(C)C[C@H](NC(CC1=CC(OCC)=C(C(O)=O)C=C1)=O)C2=CC=CC=C2N3CCCCC3
Biological Activity: Repaglinide is an insulin secretagogue for the treatment of type-2 diabetes mellitus[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Repaglinide | 99.89% | Repaglinide is an insulin secretagogue for the treatment of type-2 diabetes mellitus. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Repaglinide (Standard) | 99.96% | Repaglinide (Standard) is the analytical standard of Repaglinide. This product is intended for research and analytical applications. Repaglinide is an insulin secretagogue for the treatment of type-2 diabetes mellitus. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Repaglinide-d5 | 98.67% | Repaglinide-d5 is deuterium labeled Repaglinide. Repaglinide is an insulin secretagogue for the treatment of type-2 diabetes mellitus. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
